NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event
NeuroOne Medical Technologies (Nasdaq: NMTC), a medical technology company specializing in neurological disorder treatments, has announced its participation in the upcoming Virtual Investor Summit Microcap Event on November 21, 2024. The company will deliver a presentation from 1:30 PM to 2:00 PM ET and will be available for one-on-one meetings throughout the day.
The event will showcase 40 micro-cap companies with catalysts and/or strong market performance. Interested qualified investors can register for complimentary access to participate in live Q&A sessions and engage with leading MicroCap investors.
NeuroOne Medical Technologies (Nasdaq: NMTC), un'azienda di tecnologia medica specializzata nei trattamenti per i disturbi neurologici, ha annunciato la sua partecipazione al prossimo Virtual Investor Summit Microcap Event che si terrà il 21 novembre 2024. L'azienda presenterà dal vivo dalle 13:30 alle 14:00 ET e sarà disponibile per incontri individuali per tutta la giornata.
L'evento metterà in mostra 40 aziende micro-cap con catalizzatori e/o forti performance di mercato. Gli investitori qualificati interessati possono registrarsi per ottenere accesso gratuito e partecipare a sessioni di domande e risposte dal vivo, interagendo con i principali investitori di MicroCap.
NeuroOne Medical Technologies (Nasdaq: NMTC), una empresa de tecnología médica especializada en tratamientos para trastornos neurológicos, ha anunciado su participación en el próximo Virtual Investor Summit Microcap Event que se llevará a cabo el 21 de noviembre de 2024. La empresa realizará una presentación de 1:30 PM a 2:00 PM ET y estará disponible para reuniones uno a uno a lo largo del día.
El evento mostrará 40 empresas micro-cap con catalizadores y/o un fuerte desempeño en el mercado. Los inversores calificados interesados pueden registrarse para obtener acceso gratuito y participar en sesiones de preguntas y respuestas en vivo, así como interactuar con los principales inversores de MicroCap.
NeuroOne Medical Technologies (Nasdaq: NMTC), 신경 장애 치료를 전문으로 하는 의료 기술 회사가 2024년 11월 21일에 개최되는 Virtual Investor Summit Microcap Event에 참여한다고 발표했습니다. 회사는 오후 1시 30분부터 2시까지 ET에 발표를 진행하며, 하루 종일 일대일 미팅을 진행할 예정입니다.
이 이벤트는 카탈리스트와/또는 강한 시장 성과를 가진 40개의 마이크로캡 기업을 소개합니다. 관심 있는 자격을 갖춘 투자자는 무료로 등록하여 라이브 Q&A 세션에 참여하고 주요 마이크로캡 투자자와 소통할 수 있습니다.
NeuroOne Medical Technologies (Nasdaq: NMTC), une entreprise de technologie médicale spécialisée dans le traitement des troubles neurologiques, a annoncé sa participation au prochain Virtual Investor Summit Microcap Event qui se tiendra le 21 novembre 2024. L'entreprise présentera de 13h30 à 14h00 ET et sera disponible pour des réunions individuelles tout au long de la journée.
L'événement mettra en avant 40 entreprises micro-cap avec des catalyseurs et/ou de fortes performances sur le marché. Les investisseurs qualifiés intéressés peuvent s'inscrire pour obtenir un accès gratuit afin de participer à des sessions de questions-réponses en direct et d'interagir avec des investisseurs de premier plan dans le domaine des MicroCap.
NeuroOne Medical Technologies (Nasdaq: NMTC), ein Medizintechnikunternehmen, das sich auf die Behandlung neurologischer Störungen spezialisiert hat, hat seine Teilnahme an der bevorstehenden Virtual Investor Summit Microcap Event am 21. November 2024 bekannt gegeben. Das Unternehmen wird von 13:30 bis 14:00 Uhr ET eine Präsentation halten und steht den ganzen Tag für Einzelgespräche zur Verfügung.
Die Veranstaltung wird 40 Mikro-Cap-Unternehmen präsentieren, die über Katalysatoren und/oder starke Marktleistung verfügen. Interessierte qualifizierte Investoren können sich für den kostenlosen Zugang registrieren, um an Live-Q&A-Sitzungen teilzunehmen und mit führenden MicroCap-Investoren in Kontakt zu treten.
- None.
- None.
EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
Event: Q4 Investor Summit
Date: Thursday, November 21, 2024
Presentation Time: 1:30pm - 2:00pm ET
Location: https://www.webcaster4.com/Webcast/Page/3075/51590
The theme is 40 micro-cap companies with a catalyst and/or strong performance in the current market.
Take a deep dive with the best Investors in MicroCap
Live Q & A
Complimentary to Qualified Investors. Please REGISTER HERE.
About the Investor Summit
The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015.
About NeuroOne
NeuroOne Medical Technologies Corporation is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
Contact:
Fred Rockwell
fred@investorsummitgroup.com
Investor Summit Group
NMTC IR Contact
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group - MZ North America
NMTC@mzgroup.us
(949) 694-9594
SOURCE: NeuroOne Medical Technologies Corporation
View the original press release on accesswire.com
FAQ
When is NeuroOne Medical Technologies (NMTC) presenting at the Virtual Investor Summit?
What type of companies are featured at the November 2024 Virtual Investor Summit?
Is there a cost to attend NMTC's presentation at the Virtual Investor Summit?